PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629251
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629251
Neuroendovascular Coil Market size was valued at US$ 1,134.21 Million in 2024, expanding at a CAGR of 2.6% from 2025 to 2032.
The Neuroendovascular Coil Market involves the use of coiling procedures to treat aneurysms and other neurovascular conditions, primarily in the brain. These coils are minimally invasive and are used to occlude aneurysms, preventing rupture and subsequent bleeding. With the rise in the prevalence of neurological disorders like brain aneurysms, the demand for neuroendovascular coils is increasing globally. According to the World Health Organization (WHO), about 6 million people globally suffer from unruptured brain aneurysms. The market is also supported by advancements in imaging technologies and the development of next-generation coils, which enhance procedural outcomes. However, the high cost of these procedures, along with the complexity of the technology, poses significant challenges. In addition, limited access to healthcare facilities in developing regions and stringent regulatory approvals are also restraining market growth. On the other hand, the increasing awareness of neurovascular diseases, the growing geriatric population, and the rise in minimally invasive surgeries present significant opportunities for market growth. The rise of robotic-assisted surgeries and AI-driven diagnostic tools further promises to revolutionize this market.
Neuroendovascular Coil Market- Market Dynamics
Rising Prevalence of Brain Aneurysms Drives Growth in the Neuroendovascular Coil Market
The Neuroendovascular Coil Market is experiencing growth driven by the rising prevalence of brain aneurysms, a condition that affects around 6 million people worldwide, according to the World Health Organization (WHO). Aneurysms, if left untreated, can rupture, leading to severe neurological damage or death. As awareness of neurovascular diseases increases, more patients are seeking minimally invasive treatment options like coiling, which offers a safer alternative to traditional surgical procedures. Hospitals and healthcare systems are adopting advanced imaging technologies, such as MRI and CT angiography, to better identify aneurysms, further supporting the demand for neuroendovascular coils. The U.S. National Institutes of Health (NIH) reports that brain aneurysms account for 1-2% of the population in the U.S. alone, underlining the market potential. Additionally, with the rise of robotic-assisted procedures and AI-driven diagnostics, the efficiency and safety of coil-based treatments are improving, attracting more patients to this treatment option. This growing demand for minimally invasive solutions is expected to continue propelling the market's growth.
Neuroendovascular Coil Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.6% over the forecast period (2025-2032)
Based on product type segmentation, Bare Platinum Coils was predicted to show maximum market share in the year 2024
Based on Material segmentation, Platinum was the leading Material in 2024
Based on region, North America was the leading revenue generator in 2024
The Global Neuroendovascular Coil Market is segmented based on Product Type, Material, Application, End-User, and Region.
The market is divided into five categories based on product type: Bare Platinum Coils, Coated Coils, Hydrogel Coils, Guglielmi Detachable Coils, and Matrix. Bare Platinum Coils dominate the market due to their widespread use and proven reliability in aneurysm treatment. Guglielmi Detachable Coils follow closely, offering detachable functionality for precise placement. Coated Coils, Hydrogel Coils, and Matrix coils hold secondary positions, with specific applications in complex aneurysms.
The market is divided into two categories based on Material: Platinum and Nitinol. Platinum is the leading material in the neuroendovascular coil market due to its biocompatibility, flexibility, and ease of use in coiling procedures. Nitinol, known for its shape-memory properties, follows as a secondary choice, providing added durability in certain complex aneurysms.
Neuroendovascular Coil Market- Geographical Insights
The Neuroendovascular Coil Market is experiencing significant growth across various regions, with North America leading the market due to its advanced healthcare infrastructure and high prevalence of brain aneurysms. The U.S. is a major contributor, where approximately 1 in 50 people are affected by brain aneurysms, driving the demand for neuroendovascular treatments. Additionally, the presence of key players like Medtronic, Terumo Corporation, and Stryker in North America strengthens the market dynamics. Europe is also witnessing steady growth, with countries like Germany, the U.K., and France focusing on improving healthcare services and increasing awareness about neurovascular diseases. These regions are adopting advanced coiling technologies as part of their efforts to minimize surgical risks. In the Asia Pacific, the market is expanding rapidly, particularly in countries such as Japan, China, and India, where the rising geriatric population and improving healthcare access are increasing demand for minimally invasive treatments. Although the market is still developing in Latin America and the Middle East, the growing awareness of neurovascular health is boosting adoption in these regions as well.
The Neuroendovascular Coil Market is highly competitive, with key players continuously advancing their product portfolios to address the growing demand for minimally invasive aneurysm treatments. Leading companies in the market include Medtronic, Stryker Corporation, Terumo Corporation, Johnson & Johnson, and Boston Scientific, which dominate the market with their innovative neuroendovascular coil products. Medtronic, for instance, offers a wide range of coils for aneurysm occlusion, including its HydroCoil and Neuroform series, providing superior flexibility and stability during procedures. Stryker, with its Target(R) Coil line, and Terumo, known for its Pinnacle(TM) coils, are also at the forefront, focusing on improving coil designs to enhance clinical outcomes. Companies are increasingly investing in research and development to create more advanced materials for coils that can offer better performance in challenging anatomical structures. Strategic partnerships, mergers, and acquisitions are common in the market, as companies strive to expand their geographical reach and broaden their product offerings. With the growing demand for endovascular procedures, the competition in the market continues to intensify.
In May 2023, Cerenovus launched its CerePak detachable coils across the U.S. These neuroendovascular coils are designed for the treatment of intracranial aneurysms, offering enhanced delivery and stability, which can improve patient outcomes during endovascular procedures.
In December 2023, Terumo Medical Corporation launched the AZUR HydroPack Peripheral Coil System in the U.S. This innovative coil features proprietary hydrogel technology for mechanical occlusion, providing optimized stability and precise delivery, enhancing outcomes for interventional radiologists and vascular surgeons.